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Several studies have highlighted differences in the resistances of various mouse strains to intravenous (i.v.)
infection with Yersinia enterocolitica. In particular, differences in resistance and immunological response
between BALB/c and C57BL/6 mouse strains have been determined. Following i.v infection, C57BL/6 mice are
more resistant to Y. enterocolitica than are BALB/c mice. However, because Y. enterocolitica is typically a
food-borne pathogen, the oral route of infection more accurately reflects the natural route of infection.
Therefore, it was of interest to ascertain if the differences in resistance between mouse strains observed for an
i.v. infection can be recapitulated following an oral infection. C57BL/6j, BALB/cj, and 129X1/Svj mouse strains
presented no differences in 50% lethal dose (LD50) following oral infection with Y. enterocolitica. Subsequent
analysis of cytokine levels, bacterial colonization and immune cell populations following oral infection con-
firmed characteristics previously described following i.v. Y. enterocolitica infection. All tissues analyzed from
each mouse strain demonstrated a polarized Th1 cytokine profile and inflammatory cell influx throughout a
7-day course of infection. This immune response was present in all tissues and increased as bacterial
colonization progressed. The lack of a differing LD50 phenotype and common trends in immunological response
among the three mouse strains tested suggests that oral infection is a useful model for studying the host
response to Y. enterocolitica infection.
The genus Yersinia contains three species of human patho-
genic bacteria (13). Y. enterocolitica and Y. pseudotuberculosis
are food-borne pathogens which cause a variety of symptoms
and pathologies. Following ingestion, intestinal colonization
occurs in the underlying lymphoid tissue of the small intestine,
the Peyer’s patches (PP), and the mesenteric lymph nodes
(MLN). Y. enterocolitica infection typically results in a self-
limiting gastroenteritis and/or mesenteric lymphadenitis; how-
ever, systemic infection of deeper tissues, such as the spleen
and liver, may occur in the setting of immunosuppression or
iron overload (35).
Carter and Collins established a mouse model of Y. entero-
colitica infection in 1975 (14, 15). Subsequent studies based on
this model have been instrumental in outlining the overall
process of infection. Orally administered Y. enterocolitica can
survive the low-pH environment of the stomach at least in part
due to the expression of a urease (19, 22). Next, the bacteria
enter the small intestine, where they bind to the intestinal
epithelium (23). The bacteria then travel out of the lumen,
eventually colonizing the underlying lymphoid tissues of the
small intestine (14, 16). Once in the PP and MLN, the bacteria
are able to replicate and survive. At the same time, the host
mounts an inflammatory response characterized by an influx of
neutrophils and macrophages. (7, 31) Subsequent dissemi-
nated infection may occur, resulting in neutrophil and macro-
phage infiltration, bacterial microcolony formation, microab-
scesses, and granuloma lesion formation occurring primarily in
the MLN, liver, and spleen (6, 7, 31).
Several studies have highlighted differences in the resistance
of various mouse strains to intravenous (i.v.) infection with Y.
enterocolitica. BALB/cBy, BALB.B, Swiss, C3H/HeN, A, SWR,
and DBA/2 mouse strains are more susceptible to i.v. infection
than are C57BL/6 mice (26). For these mouse strains, the i.v.
50% lethal dose (LD50) is 3  10
2 to 6  102, while the
C57BL/6 strain is more resistant, with an i.v. LD50 of 2  10
5
which is 667-fold higher than that for the BALB/cBy LD50 of
3  102. BALB/cBy parentally crossed with C57BL/6 produces
an F1 progeny with an intermediate level of resistance (LD50 
3  104), suggesting that the level of resistance is genetically
linked. C57BL/6 mice were also shown to have decreased bac-
terial colonization in the PP compared to BALB/cBy mice
following oral infection. In a similar study by Autenrieth et al.,
the i.v. LD50 for C57BL/6 mice was 2  10
4, 40-fold higher
than that for the BALB/c mice which was of 5  102 (2). The
above studies went on to demonstrate that resistance to i.v. Y.
enterocolitica infection is not linked to the Salmonella resis-
tance locus, Ity, or to the H-2 locus (26). Further inbreeding
tentatively identified a potential resistance gene carried by
C57BL/6 but not BALB/c mice (25). The ES-1 locus encodes
an esterase of unknown function; however, the overall level of
resistance appears to be a multigenic trait.
Although the above studies have elucidated a number of
details concerning the host response to i.v.-administered Y.
enterocolitica, naturally acquired Y. enterocolitica infection typ-
ically occurs following ingestion and uptake into the gastroin-
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testinal tract, not direct injection into the bloodstream. There-
fore, the primary goal of this study was to determine if the
differences observed between mouse strains when using the
i.v.-infection model were paralleled when using an oral-infec-
tion model. Resistance to orally administered Y. enterocolitica
was assessed in C57BL/6j, BALB/cj, and 129X1/Svj inbred
mouse strains. These strains were chosen due to their historical
use in the study of Y. enterocolitica and bacterial pathogenesis
in general. We analyzed LD50s, levels of five representative
Th1/Th2 cytokines (tumor necrosis factor alpha [TNF-],
gamma interferon [IFN-], interleukin-2 [IL-2], IL-5, and IL-
4), 11 different cell populations, and colonization and associ-
ated pathology of various tissues for each mouse strain on days
1, 3, and 7 postinfection. This information will be useful for
studies utilizing the oral model and for comparison with data
obtained from studies using alternate routes of infection.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The Y. enterocolitica strain used in
this study, JB580v, is a restriction-minus derivative of a virulent American strain,
8081v, serogroup O:8 Nalr (28). JB580v was grown at 26°C overnight with
aeration in Luria-Bertani (LB) broth or on LB agar plates supplemented with 20
g of nalidixic acid (Sigma Chemicals, St. Louis, Mo.) per ml. Actual numbers of
CFU administered were determined by serial dilutions of the overnight culture
followed by plating on LB agar plates containing 20 g of nalidixic acid per ml.
Mice. Virus-free C57BL/6j, BALB/cj, and 129X1/Svj mice were purchased
from the Jackson Laboratory (Bar Harbor, Maine). The animals were housed in
plastic cages with wood shavings in a high-efficiency particulate air-filtered bar-
rier unit maintained at 25°C with alternating 12-h periods of light and dark. The
mice had drinking water at all times and were fed ad libitum with an autoclaved
rodent pellet diet. They were infected orally with 0.1 ml of the indicated doses of
bacteria via a 21-gauge feeding tube attached to a 1.0-ml syringe or i.v. through
the tail vein with 0.1 ml of bacteria resuspended in phosphate-buffered saline
(PBS). The Washington University Animal Studies Committee approved all
animal experiments.
LD50, survival curves, and kinetics analysis. Six groups of five to six mice from
each genetic background were infected either orally or i.v. with successive 10-fold
dilutions of the bacterial suspension (oral, 104 to 109 bacteria; i.v., 101 to 105
bacteria). The mice were monitored twice daily for a 14-day period. This analysis
was done in duplicate in two independent experiments for each mouse strain. For
kinetic analysis, mice were sacrificed by CO2 asphyxiation at various times postin-
fection (1, 3, or 7 days) following infection with 1  108 to 8  108 bacteria in a
volume of 100 l. Tissues (PP, MLN, and spleen) were surgically removed and
weighed. The bacterial load recovered from the infected organs was determined
by plating serial dilutions of the macerated tissues on LB plates containing 20 g
of nalidixic acid per ml to select for Nalr Y. enterocolitica. Results are reported as
CFU per gram of tissue (between 2 and 110 mg for PP, between 5 and 182 mg
for MLN, and between 14 and 1415 mg for spleens). Kinetic analysis was done
in duplicate as two independent experiments for each mouse strain.
Histopathology. Mice from each genetic background were orally infected with
1  108 to 8  108 CFU. Uninfected mice (day 0) and mice infected for 1, 3, or
7 days were sacrificed by CO2 asphyxiation. The small intestine, MLN, and
spleen were removed. The lumen of the small intestine was flushed with PBS, and
all tissues were fixed in either 10% neutral buffered formaldehyde or Bouin’s
fixative prior to being embedded in paraffin, sectioned, and stained with hema-
toxylin and eosin or with Y. enterocolitica specific antibody (20). The sections
were scored for increased numbers of macrophages and neutrophils, granuloma
formation, inflammatory infiltrates, necrosis, and bacterial colonization. A min-
imum of five mice per time point were examined.
Single-cell suspension preparation. Four mice from each genetic background
were sacrificed by CO2 asphyxiation on day 0, 1, 3, and 7 postinfection, and their
spleens, MLN, and PP were surgically removed and placed in ice-cold HBSS
(Ca2- and Mg2-free Hanks’ balanced salt solution [HBSS; BioWhittaker,
Walkersville, Md.] supplemented with 1% fetal calf serum [FCS] [HyClone,
Logan, Utah] and 50 U of penicillin per ml–50 mg of streptomycin per ml [both
from BioWhittaker]). The tissues were ground between sterile frosted glass
slides, and the homogenates were incubated for 30 min at 37°C under 5% CO2
and humidity in RPMI medium (BioWhittaker) supplemented with 10% FCS, 2
mM Glutamax (alynyl-L-glutamine [Invitrogen, Carlsbad, Calif.]), 50 U of pen-
icillin per ml–50 mg of streptomycin per ml, 1 mg of collagenase D (Sigma
Chemicals) per ml, and 1 U of DNase (Fisher Scientific, Pittsburgh, Pa.) per ml.
Cell suspensions were filtered through 40-m-pore-size filters (BD Labware,
Franklin Lakes, N.J.), washed twice with ice-cold HBSS, resuspended in the
above tissue culture medium without DNase or collagenase D and allowed to
recover for 1.5 h at 37°C under 5% CO2 and humidity. Red blood cells were lysed
from spleen samples by incubating the cell suspensions for 5 min at room
temperature in 17 M Tris–140 M NH4Cl followed by two washes in ice-cold
HBSS. Cells were resuspended in the above RPMI tissue culture medium
without collagenase D and DNase. Cell viability and number were assessed by
trypan blue exclusion.
Flow cytometry. Single-cell suspensions obtained as described above were
resuspended in PBS with 0.05% (wt/vol) bovine serum albumin fraction V
(Sigma Chemicals), and FC block (2.4G2; BD Pharmingen, San Diego, Calif.) at
2  107 cells ml1. Then 106 cells were stained with marker-specific fluorophore
(fluorescein-5-isothiocyanate [FITC] or phycoerythrin [PE])-conjugated antibod-
ies (Abs), biotin-conjugated Abs, or the appropriate isotype control Abs for 30
min on ice. Cellular suspensions were then washed twice in PBS containing 1%
bovine serum albumin fraction V and, where appropriate, stained with appro-
priate fluorophore-conjugated secondary Abs, streptavidin-PE, or streptavidin-
FITC for 30 min on ice. The cells were washed twice as described above and fixed
with 1% paraformaldehyde in PBS. Flow cytometric analysis was done on a
triple-laser flow cytometer (FACS calibur; BD Biosciences, Mountain View,
Calif.), and analysis was performed using the CellQuest program (BD Bio-
sciences) and WinMDI v2.8 (Scripps Research Institute, La Jolla, Calif.). Dead
cells were excluded based on forward and side light scatter. For the analysis of
lymphocyte subpopulations, 10,000 cells from the lymphocyte population (as
determined by forward versus side scatter) were analyzed for the expression of
lymphocyte markers. For the analysis of nonlymphocyte subpopulations, 10,000
cells from a gate surrounding the lymphocyte population and extending to the
edge of the side scatter were analyzed.
The following Abs and secondary staining reagents were used for flow cyto-
metric studies: biotin-conjugated rat anti-mouse Ly-6G (Gr-1: RB6-8C5), biotin-
conjugated hamster anti-mouse T-cell receptor (TCR)  chain (H57-597),
PE-conjugated rat anti-mouse CD19 (1D3), FITC-conjugated rat anti-mouse
LY-49G2 (4D11), PE-conjugated hamster anti-mouse CD11c (HL3), PE-conju-
gated hamster anti-mouse 	 T-cell receptor (GL3), FITC-conjugated rat anti-
mouse CD4 (RM4-5), FITC-conjugated rat anti-mouse CD8a (53-6.7), PE-con-
jugated rat anti-mouse CD25 (PC61), PE-conjugated rat anti-mouse CD62L
(MEL-14), FITC-conjugated hamster anti-mouse CD3ε chain (145-2C11), and
appropriate isotype control Abs, streptavidin-FITC, streptavidin-PE (all from
BD Pharmingen), and biotin-conjugated rat anti-mouse BM8 (Novus Biologicals,
Littleton, Colo.).
Preparation of bone marrow-derived macrophages (BMM). Three mice from
each genetic background were sacrificed and had both femurs surgically removed
and collected into 10 ml of ice-cold Dulbecco modified Eagle Medium (Bio-
Whittaker) supplemented with 10% FCS, 2 mM Glutamax, and 50 U of penicillin
per ml–50 mg of streptomycin per ml. The end of each femur was removed using
sterile scissors, and the bone marrow was flushed into a bacterial petri dish using
a 26-gauge syringe and 10 ml of ice-cold cell culture medium. Single-cell sus-
pensions were made by repeatedly pipetting the cells through a 10-ml pipette.
The cells were incubated at 37°C under 5% CO2 and humidity for 8 days at a
density of 107 cells in bacterial petri dishes containing 10 ml of medium as
described above supplemented with 20% L-cell medium. The cells were given 10
ml of fresh supplemented medium after 4 days. On day 8, visual inspection of the
cells revealed a confluent monolayer of adherent cells. Nonadherent cells were
removed by washing twice with room temperature PBS. Adherent cells were
removed by incubation with 10 ml of ice-cold PBS–1.0 mM EDTA (pH 7.4) for
10 min. The cells were then resuspended in medium free of penicillin and
streptomycin and supplemented with 20% L-cell medium and distributed into
96-well dishes at 105 cells per well.
In vitro lymphocyte stimulation. BMM were loaded with antigen by overnight
incubation with 10 g of heat-killed (95°C for 30 min) Y. enterocolitica (HKY)
organisms per ml (7). For determination of cytokine production, 2.5  105 cells
from each cell suspension described above (PP, MLN, and spleens) from each
mouse strain on days 0, 1, 3, and 7 were cocultured with the HKY-stimulated
BMM for 48 h. Supernatants were collected and frozen at 80°C for subsequent
cytokine analysis. The stimulation was done in duplicate in two independent
experiments for each mouse strain.
Cytokine analysis. Levels of IFN-, TNF-, IL-5, IL-4, and IL-2 were deter-
mined using the mouse Th1/Th2 cytokine cytometric bead array kit (BD Bio-
sciences). Culture supernatants (50-l volumes) were analyzed as specified by
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the manufacturer. The analysis was done in duplicate with samples from two
different experiments for a total of four replicates. Cytokine concentrations were
calculated using cytometric bead array analysis software v 1.2 (BD Biosciences).
Statistical analysis. LD50s were determined by the methods of Reed and
Muench (32). All statistical analyses were performed using GraphPad Prism
v.3.03 (Graphpad Software, San Diego, Calif.). Survival curves were constructed
using the Kaplan-Meier method and compared using the Mantel-Haenszel log-
rank test (1). Nonparametric analysis of variance (ANOVA) using the Kruskal-
Wallis test and Dunns post test were used to compare the means of experimental
groups. A P value of 
0.05 was considered statistically significant.
RESULTS
Survival of C57BL/6j, BALB/cj, and 129X1/Svj mice follow-
ing oral administration of Y. enterocolitica. Previous studies
have reported a mouse strain-dependent difference in resis-
tance to i.v. administered Y. enterocolitica (C57BL/6 mice are
40- to 667-fold more resistant than BALB/c) (2, 26). This
phenotype was confirmed using our wild-type laboratory strain
of Y. enterocolitica (JB580v) in C57BL/6j and BALB/cj mice.
Following i.v. administration, the LD50 in C57BL/6j mice was
118-fold greater than in BALB/cj mice (LD50, 5.9  10
4 for
C57BL/6j and 5  102 for BALB/cj). To determine if a similar
phenotype was observable following oral administration of Y.
enterocolitica, an LD50 analysis was done using C57BL/6j,
BALB/cj, and 129X1/Svj mouse strains. There was little differ-
ence between the LD50s for C57BL/6j mice and 129X1/Svj
mice (Table 1). There was a 5.1-fold difference between the
LD50s for BALB/cj mice and C57BL/6j mice and a similar
(2.3-fold) difference between those for BALB/cj mice and
129X1/Svj. This correlates with previous reports in the litera-
ture that BALB/c mice are more susceptible to i.v.-adminis-
tered Y. enterocolitica. However, this difference was much
smaller and was not statistically significant following duplicate
LD50 analysis (P  0.2636).
Survival curves using combined data sets from both LD50
analyses were constructed and compared by using the Mantel-
Haenszel log-rank test (Fig. 1). There was no statistically sig-
nificant difference between the survival curves of each mouse
strain (BALB/cj versus C57BL/6j, P  0.3812; BALB/cj versus
129X1/Svj, P  0.2465; C57BL/6j versus 129X1/Svj, P 
0.8100). Furthermore, the mice did not die at significantly
different rates, as indicated by their hazard ratios (Table 1).
Colonization of 129X1/Svj, C57BL/6j, and BALB/cj mouse
tissues following oral infection with Y. enterocolitica. Kinetic
analysis was done to determine levels of bacterial colonization
in the PP, MLN, and spleens from each mouse strain. Hancock
et al. previously showed decreased colonization of C57BL/6 PP
tissue compared with infected BALB/cBy mouse tissue follow-
ing oral infection with Y. enterocolitica (26). In this study,
tissues were analyzed for their bacterial titers (CFU per gram
of tissue) on days 1, 3, and 7 postinfection (Fig. 2). All 84 mice
used in the study had detectable bacterial colonies in the PP as
early as day 1 postinfection. Bacterial levels in the PP were
consistently high (mean CFU per gram, 6.2 107 to 7.4  109)
throughout the course of infection for all mouse strains (Fig.
2A). Furthermore, there was little variability with the data
obtained from PP tissue compared to MLN and spleens (stan-
dard deviations [SD] from log-transformed data: PP  0.50 to
1.02; MLN  0.69 to 3.03; spleens  1.27 to 4.72). There were
no statistically significant differences (P 
 0.05) between the
mean daily levels of colonization in the PP between the mouse
strains.
Many of the MLN lacked colonization until day 3 postinfec-
tion (Fig. 2B). Consistent colonization was observable by day 3
and remained high through day 7, when a majority of the
lymph nodes were colonized to very high levels (69% of MLN
colonized on day 1, 96% on days 3 and 7). C57BL/6j MLN had
significantly lower levels of colonization than did BALB/cj
MLN (P 
 0.05) on day 3 or 129X1/Svj MLN (P 
 0.001) on
days 3 and 7 postinfection (C57BL/6j versus 129X1/Svj, P 

0.001). Colonization of C57BL/6j MLN was also more variable
than the BALB/cj and 129X1/Svj data (SD of log-transformed
data: day 3, C57BL/6j  2.39, BALB/cj  1.20, 129X1/Svj 
FIG. 1. LD50 analysis. Survival curves for three strains of mice over
a 14-day period are shown. Survival percentages were calculated using
the Kaplan-Meier method (1). Six groups of five or six mice from each
genetic background were infected orally with successive 10-fold dilu-
tions of the bacterial suspension (104 to 109 bacteria) and monitored
twice daily for 14 days. The analysis was done in duplicate in two
independent experiments.
TABLE 1. Duplicate LD50 analysis for each mouse strain
a
Mouse
strain
First LD50
(CFU)
Second LD50
(CFU)
Avg LD50
(CFU)
Fold change
vs. BALB/Cj
Hazard ratio
(CI95%)b
129X1/Svj 2.0  107 4.0  106 1.2  107 2.3 1.398 (0.785–2.569)
C57BL/6j 3.7  107 1.8  107 2.7  107 5.1 1.306 (0.711–2.442)
BALB/cj 7.8  106 2.8  106 5.3  106
a LD50 were determined by the methods of Reed and Muench (32).
b Ratio comparing the rate of death (slope) of BALB/cj mice to the other mouse strains. A hazard ratio of 1 would indicate equal death rates (1). CI95% is the 95%
confidence interval.
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0.69; day 7, C57BL/6j  3.03, BALB/cj  1.96, 129X1/Svj 
0.42).
Spleens, similar to the MLN, had increasingly consistent
bacterial colonization throughout the 7-day course of infection
(42% of spleens colonized on day 1, 86% on day 3, and 89% on
day 7 postinfection) (Fig. 2C). There were no statistically sig-
nificant differences (P 
 0.05) in the mean bacterial coloniza-
tion between mouse strains on each day. Variation increased in
data gathered from spleens as infection progressed (SD of
log-transformed data: day 1, 1.27 to 2.01; day 3, 1.74 to 2.06,
day 7, 2.93 to 4.72). A majority of the 129X1/Svj mouse spleens
were not colonized until day 7 of infection, in contrast to the
spleens of C57BL/6j and BALB/cj mice, which were colonized
by day 3 (day 3 spleen colonization: C57BL/6j, 100%; BALB/cj,
90%; 129X1/Svj, 63%). Although more of the 129X1/Svj
spleens become colonized by day 7, this colonization is limited
to a small number of bacteria compared to the levels in
C57BL/6j and BALB/cj mice.
Increases in tissue weights were used as a further indicator
of disease severity and progression. A previous study indicated
that following an i.v. infection with Y. enterocolitica, C57BL/6
mice developed splenomegaly 7 days postinfection while
BALB/c mice did not (2). In this study, all tissues from all three
mouse strains increased in weight over the 7-day period of
infection (data not shown). This increase was equivalent
among the three strains of mice for the PP and the MLN.
However, the 129X1/Svj mice showed a more significant in-
crease in spleen weight on day 7 postinfection than did
C57BL/6j (P  0.0066) and BALB/cj (P  0.0070) mice (dif-
ference in spleen weight between days 1 and 7: C57BL/6j,
0.0313 g; BALB/cj, 0.0204 g; 129X1/Svj, 0.1985 g).
Histological analysis revealed inflammatory pathologies pre-
viously described for Y. enterocolitica-infected tissues (4, 6, 31).
Significant differences in pathology among mouse strains were
not apparent in all tissues analyzed. No inflammation was
apparent in uninfected mouse tissues; however, bacterial col-
onization always correlated with pathology. Inflammation and
tissue destruction was noticeable in PP of mice as early as day
1 postinfection (Fig. 3). This early response was restricted to
the area just beneath the dome of the PP and was almost
always associated with bacteria. By day 3 postinfection, PP
were frequently completely ablated, consisting of dead cells,
bacterial colonies, granulolcytes, and macrophages (Fig. 3).
The severity of this pathology was similar to what was seen on
day 7 postinfection (data not shown).
Noticeable pathology was not present in the MLN until day
3 postinfection (Fig 4). The pathology in the MLN differed
significantly from that in the PP and consisted primarily of
granuloma-like lesions. These lesions were the most common
pathological phenotype and consisted of a ring of inflammatory
cells surrounding all visible bacterial colonization. These gran-
uloma-like lesions were never observed in infected PP.
A similar granuloma-like lesion was observed in the spleens
of all three mouse strains (data not shown). This pathology was
rarely evident on day 3 but increased in frequency in the
spleens of mice infected for 7 days.
Levels of representative Th1 and Th2 cytokines produced by
cell suspensions from C57BL/6j, BALB/cj, and 129X1/Svj PP,
MLN, and spleens. Th-cell phenotypes are characterized into
Th1 or Th2 subsets on the basis of the cytokines they produce
FIG. 2. Kinetic analysis. CFU per gram of tissue in the PP (A),
MLN (B), and spleens (C) of mice infected for 1, 3, or 7 days are
shown. Results from two independent experiments were combined.
Analysis was performed in duplicate for each mouse strain (C57BL/6j,
dose 1  8  108 and dose 2 dose  1  108; BALB/cj, dose 1  1 
108 and dose 2  5  108); 129X1/Svj, dose 1  5  108 and dose 2 
5  108). The limit of detection for each tissue is indicated by a dashed
line. Nonparametric ANOVA using the Kruskal-Wallis statistic and
Dunns post-test was used to compare mean CFU/gram of tissue for
each day. Symbols at the limit of detection represent mice that survived
but did not have detectable numbers of bacteria. Two C57BL/6j mice
died by day 7.
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FIG. 3. Histological analysis of PP following oral infection with Y. enterocolitica. Peyer’s patches were removed from uninfected mice (day 0)
and infected mice on days 1 and 3 postinfection. Tissues were fixed in either 10% neutral buffered formalin or Bouin’s fixative and embedded in
paraffin for sectioning. Sections (5 m) were stained with hematoxylin and eosin (A to I) or with Y. enterocolitica-specific Ab (J to R), indicated
by the brown staining. Arrows indicate regions of inflammation seen on day 1 postinfection. Arrowheads indicate Ab stained bacterial colonies and
corresponding inflammation.
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(29). Both subsets provide assistance to innate immune cells in
killing microbial pathogens and polarizing subsequent adaptive
cellular immune responses. Th1 cells which characteristically
produce IFN- can activate macrophages, helping them to kill
extracellular and intracellular pathogens which resist killing
after being engulfed. Th2 cells predominantly produce IL-4,
IL-5, and IL-13 and can initiate the humoral immune response
by activating naive antigen-specific B cells to produce immu-
noglobulin M (IgM) and subsequently different isotypes of Ig.
Previous studies using the i.v. model of Y. enterocolitica infec-
tion have demonstrated that in a mouse, the IFN- producing
Th1 phenotype predominates during Y. enterocolitica infection
(2, 5, 9–11, 27). However, a comprehensive study of Th1 and
Th2 cytokine production in different tissues following oral in-
fection has yet to be done. Therefore, the levels of several
characteristic Th1 (IFN- and IL-2) and Th2 (IL-5 and IL-4)
cytokines and the proinflammatory cytokine TNF- were mea-
sured from cell populations isolated from uninfected and in-
fected mice on days 1, 3, and 7 postinfection. Cytokine pro-
duction was measured by coculturing single-cell suspensions
from infected PP, MLN, and spleens exposed to HKY-loaded
antigen-presenting cells.
TNF- levels in all tissues do not increase until after day 1
postinfection (Fig. 5A to C). The PP of BALB/cj mice pro-
duced increasing levels of TNF- throughout the 7-day period
of infection, while levels in C57BL/6j and 129X1/Svj mice in-
creased on day 3 but had receded by day 7. Levels of TNF-
increased from 5.3- to 13.6-fold between days 1 and 3 in the
MLN of all three strains of mice (Fig. 5B). The levels in the
spleens also increased between days 1 and 3 by approximately
6.0- to 10.6-fold (Fig. 5C). However, on day 7, the spleens of
129X1/Svj mice contained higher TNF- levels than did those
of both C57BL/6j and BALB/cj mice.
Basal levels of IFN- were equivalent among mouse strains
for all tissues analyzed (Fig. 5D to F). Increased IFN- pro-
duction was not detected until day 3 postinfection. IFN- levels
in the isolated cell suspensions from PP of each mouse strain
reached a plateau between days 3 and 7 postinfection, with
overall levels being lower in the PP of C57BL/6j mice (Fig.
5D). IFN- levels were several log units higher in the MLN and
spleens than in the PP. There was no difference in the levels of
IFN- in the MLN in all three strains of mice throughout the
time course of infection (Fig. 5E). IFN- levels in the spleens
of all three mouse strains increased on day 3 post-infection.
However, the levels on day 7 increased dramatically in 129X1/
Svj mice while receding in C57BL/6j and BALB/cj mice (Fig.
5F).
IL-2 levels were below the limit of detection (20 pg ml1) in
all tissues in each mouse strain at each time point analyzed,
except in the spleens of 129X1/Svj mice (data not shown). On
Day 0 Day 3
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FIG. 4. Histological analysis of MLN following oral infection with Y. enterocolitica. MLN were removed from uninfected and infected mice on
day 3 postinfection. Tissues were fixed in either 10% neutral buffered formalin or Bouin’s fixative and embedded in paraffin for sectioning. Sections
(5 m) were stained with hematoxylin and eosin (A, B, D, E, G, and H) or with Y. enterocolitica-specific Ab (C, E, and I), indicated by the brown
staining.
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day 7, splenocytes from 129X1/Svj mice produced detectable
levels of IL-2 (24.2 pg ml1) while those of C57BL/6j and
BALB/cj mice did not.
Overall Th2 cytokine (IL-4 and IL-5) levels were below the
limit of detection (20 pg ml1) in the tissues of all three strains
of mice at each time point analyzed (data not shown). Collec-
tively, the combined cytokine profile in tissues from all three
mouse strains is proinflammatory (increasing levels of TNF-),
with a Th1 phenotype (increasing IFN- level, no increase in
IL-4 or IL-5 levels).
FACS analysis of infected and uninfected tissues of C57BL/
6j, BALB/cj, and 129X1/Svj mice. Fluorescence-activated cell
sorter (FACS) analysis for cell types involved in the innate and
adaptive immune response was performed to characterize the
different types of immune cells present in different tissues
before and after the initiation of an oral Y. enterocolitica in-
fection. Single-cell suspensions from the PP, MLN, and spleens
of all three mouse strains were analyzed for uninfected and
infected mice on days 1, 3, and 7 postinfection.
The quantities of granulocytes (Gr-1) and macrophages
(BM-8) were measured to partially characterize the innate
immune compartment of each tissue following oral Y. entero-
colitica infection (Fig. 6). Gr-1 cell numbers in the PP in-
creased rapidly between days 1 and 3 in C57BL/6j (sevenfold),
129X1/Svj (fourfold), and BALB/cj (fourfold) mice, with high
levels in all three mouse strains by day 7 postinfection (C57BL/
6j, 41%; BALB/cj, 56%; 129X1/Svj, 41%). Overall, there were
smaller numbers of Gr-1 cells in the MLN and spleen of each
mouse strain than in the PP. There was little difference be-
tween mouse strains in the levels or in the increase in the
numbers of Gr-1 cells in the MLN. However, C57BL/6j mice
had a threefold increase in the numbers of Gr-1 cells in their
spleens compared to the relatively small change observed in
either the BALB/cj or 129X1/Svj mice.
Recruitment of macrophages during infection as determined
by BM-8 staining showed recruitment to the PP, MLN, and
spleens of all three mouse strains (Fig. 6). Variation in BM-8
recruitment among mouse strains was evident in the MLN,
with the level in BALB/cj mice increasing eightfold, on con-
trast to the levels in C57BL/6j (only twofold) and 129X1/Svj
(threefold) mice over the 7-day course of infection. There was
a similar yet smaller increase in the number of BM-8 cells in
the PP and spleens of BALB/cj mice compared to those in
C57BL/6j and 129X1/Svj mice (PP: C57BL/6j  threefold,
BALB/cj fourfold, 129X1/Svj twofold; spleen: C57BL/6j
twofold, BALB/cj  threefold, 129X1/Svj  twofold). Al-
though 129X1/Svj mice started with similar numbers of BM-8
cells in their PP and MLN, the level this cell type did not
increase as extensively throughout infection as it did in
C57BL/6j and BALB/cj PP and MLN (Fig. 6D and E).
The levels of natural killer (NK) cells (Ly49g), and den-
dritic cells (CD11c) were also analyzed and found to consis-
tently be less than 1 to 3% of the cell population and to change
little during the time course analyzed (data not shown).
The adaptive immune compartment was assessed by quan-
tifying the levels of B cells (CD19), and several subsets of T
cells including  T cells (TCR), 	 T cells (	TCR),
CD8 T cells (TCR-CD8), CD4 T cells (TCR-
CD4), regulatory T cells (CD4-CD25), and activated T
cells (CD3-CD62L) (Fig. 7).
FIG. 5. Cytokine production by cell suspensions from C57BL/6j (), BALB/cj (F), and 129X1/Svj (Œ) mouse tissue suspensions cocultured with
HKY-stimulated macrophages. Levels of TNF- (A to C) and IFN- (D to F) measured following 48 h of incubation are shown. Cells were isolated
from PP, MLN, and spleens of uninfected mice (day 0) and infected mice on days 1, 3, and 7 postinfection.
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129X1/Svj PP contained more cells expressing the -TCR
both before and after oral infection with Y. enterocolitica than
did PP of both C57BL/6j and BALB/cj mouse strains (Fig. 7A).
The levels of -TCR-expressing cells also remained fairly
constant in the C57BL/6j and BALB/cj mouse strains through-
out the 7-day course of infection. This contrasts with what was
observed in the MLN of all three mouse strains. During infec-
tion, there was a 25% average decrease in the -TCR-ex-
pressing cells in all mouse strains during the 7-day course of
infection (Fig. 7B). The cell population expressing the -TCR
in the spleen fluctuated between 25 and 50%; however, over
the 7-day course of infection, there was no difference in the
increase or decrease of these cells, except that BALB/cj mice
had increased numbers before and throughout the course of
infection compared with C57BL/6j and 129X1/Svj mice (Fig.
7C). The levels of 	 T cells and regulatory T cells (CD4
CD25) were less than 1 to 3% in all tissues and mouse strains
throughout infection (data not shown).
CD-19 were the predominant cell type identified in the PP
of all three strains of mice. CD19-expressing B cells remained
at constant levels in the PP of each mouse strain over the 7-day
course of infection (Fig. 7G to I). In contrast, the levels of
CD19 B cells steadily increased by 3.5 to 5.0-fold in the MLN
and 2-fold in the spleens of each mouse strain (Fig. 7H).
Both BALB/cj and 129X1/Svj mice had higher CD4-to-
CD8 ratios (more CD4 Th cells than CD8 cytotoxic T
cells) than did C57BL/6j mice, which had more CD8 T cells
in all tissues analyzed (Fig. 7D to F). The ratio difference is due
to C57BL/6j mice having both more CD8 and fewer CD4
cells in all tissues and at all time points. This difference remains
constant in the PP, MLN, and spleens throughout the duration
of the Y. enterocolitica infection.
CD62L (L-selectin) is a T-cell outer membrane protein
which can be used to monitor T-cell activation. Resting naive
T cells express L-selectin, which they use for homing to pe-
ripheral lymph nodes (34). On T-cell activation, L-selectin
expression is lost. We monitored the quantity of CD3-
CD62L versus CD3-CD62L cells as a marker of T-cell
activation. Of the CD3 T cells remaining as infection pro-
gressed, CD3 cells gradually reduce CD62L expression in
each tissue analyzed from each mouse strain (Fig. 7J to L). The
only exception to this was the MLN of 129X1/Svj mice, which
have similar numbers of CD3-CD62L cells at on day 7
postinfection to those in uninfected mice (Fig. 7K). This de-
crease was more immediate in the PP and spleens than in the
MLN. The number of CD3-CD62L T cells was greater in
the spleens of C57BL/6j and BALB/cj mice than in spleens of
129X1/Svj mice (Fig. 7L).
DISCUSSION
Studies initiated by Autenrieth and followed up on by Bohn
and Autenrieth have demonstrated several potential mecha-
nisms to explain the increased resistance of C57BL/6 mice to
BALB/c mice in an i.v.-administered Y. enterocolitica infection
model (2, 3, 9–12, 27). Their work demonstrates that as an
i.v.-administered infection progresses, C57BL/6 mouse spleens
mount a more pronounced inflammatory response than do
BALB/c mouse spleens. This tissue-specific response is char-
acterized by splenomegaly, bacterial clearance, and more rapid
activation of both CD4 and CD8 T cells (2). Splenic T cells
transferred from C57BL/6 mice to naive mice 7 days after
infection provided protective immunity (2). Similar protective
immunity for BALB/c mice was demonstrated but required T
cells isolated 21 days postinfection. Splenocytes isolated from
i.v.-infected C57BL/6 mice were also able to proliferate and
FIG. 6. Immunophenotyping. FACS analysis was performed on cell suspensions from C57BL/6j (), BALB/cj (F), and 129X1/Svj (Œ) mouse
tissues following oral infection with Y. enterocolitica. Values on the y axis indicate the percentage of cells from a gate encompassing all live cells
(Gr-1, granulocytes; BM-8, macrophages).
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produced IFN- more rapidly in response to stimulation with
HKY and IL-12 than did splenocytes from BALB/c mice (9).
Furthermore, treatment of BALB/c mice with IFN-, IL-12, or
anti-IL-4 rendered them more resistant but had little to no
effect on Y. enterocolitica infection in C57BL/6 mice (2). Taken
together, these studies suggest that BALB/c mice have delayed
splenic T-cell activation correlating with levels in Th1 cyto-
kines, resulting in a state of increased susceptibility compared
with C57BL/6 mice.
Although the above studies have elucidated a number of
molecular and cellular mechanisms involved in Y. enterocolitica
pathogenesis, many of them have been out of the context of the
typical route of infection. i.v. administration of bacteria imme-
diately exposes the host to a systemic infection with the pri-
mary sites of infection, i.e., those that filter blood, such as the
spleen and liver. However, Y. enterocolitica is usually naturally
acquired via an oral route (e.g., ingestion of contaminated
food), which exposes the bacteria to the mucosal immune
environment of the small intestine prior to dissemination to
deeper tissues such as the spleen, lungs, and liver.
In this study, we present data that suggest when Y. entero-
colitica is administered via the oral route, host resistance, as
determined by LD50 and survival curve analysis, is highly sim-
ilar among C57BL/6j, BALB/cj, and 129X1/Svj mouse strains.
This contrasts with results of i.v. infection studies completed in
our and other laboratories, in which C57BL/6j mice are more
resistant than BALB/c mice (2, 25, 26). Furthermore, the bac-
teria were capable of colonizing the PP of the small intestine
and subsequently spreading into the MLN and spleens of each
mouse strain tested. Although consistently high levels of bac-
FIG. 7. Immunophenotyping. T-cell populations and B cells from C57BL/6j (), BALB/cj (F), and 129X1/Svj (Œ) tissues following oral
infection with Y. enterocolitica are shown. Values on y axis indicate the percentage of cells from the lymphocyte gate (TCR, mature T-cells;
CD3-CD62L, activated T cells; CD-19, B cells) or ratios of these values (CD4, Th cells; CD8, cytotoxic T cells).
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teria were detected in the PP of orally infected mice, differ-
ences in the levels of bacterial colonization increased between
mouse strains as the bacteria disseminated into the MLN and
spleen of each mouse strain. This was particularly evident in
the MLN of C57BL/6j mice, which had lower levels of bacteria
than did the MLN of both BALB/cj and 129X1/Svj mice on day
3 postinfection. This may be reflective of previous studies using
the i.v.-infection model, in which C57BL/6 mice are generally
able to control bacterial colonization better than BALB/c mice.
Although there were quantitative differences in the levels of
bacterial colonization in these tissues between mouse strains,
the strains exhibited a similar pattern of tissue colonization
and corresponding tissue pathology as determined by a de-
tailed histological analysis. Therefore, each mouse strain could
be useful in studies concerning the infectious processes occur-
ring in the PP and MLN of mice orally infected with Y. entero-
colitica.
Colonization of C57BL/6j and BALB/cj mouse spleens be-
came increasingly varied as infection progressed. Levels of
bacterial colonization in these strains varied over a 6- to 8-log-
unit range on days 3 and 7 postinfection. This increased vari-
ation was not apparent in the spleens of 129X1/Svj mice
throughout the course of infection. The ability of 129X1/Svj
mice to maintain consistently low levels of bacteria in their
spleen may be due to the increased production of TNF- and
IFN- compared with the C57BL/6j and BALB/cj mouse
strains (see below).
The increased variation of splenic colonization raises spe-
cific challenges in analyzing the host response in the spleens
following oral infection with Y. enterocolitica. Not only will
there be different responses in individual spleens due to quan-
titative differences in bacterial colonization, but also there
could potentially be variation due to the variation in the fre-
quency of colonization. This effect is most prominent early
during infection, when many spleens lack any detectable colo-
nization, and becomes less severe on day 7, when colonization
is more frequent. Variation in the frequency of colonization
will result in two populations of spleens: one which is respond-
ing to both colonization of itself and to colonization at other
sites in the animal such as the PP and MLN, and one which is
not colonized and is responding only to events occurring else-
where in the animal. There are two basic approaches which can
be taken to deal with this phenomenon. For this study, we
combined the spleens of many mice in an attempt to screen for
global immunological responses occurring during infection.
This may have potentially masked responses differing between
the two populations of spleens. An alternative approach would
be to analyze individual spleens of mice for bacterial coloni-
zation and cellular and molecular immune responses simulta-
neously. This approach may prove to be more useful when
asking questions concerning a specific cellular or molecular
event involving oral Y. enterocolitica infection.
Along with demonstrating a difference in LD50 of i.v.-ad-
ministered Y. enterocolitica infection between mouse strains
Hancock et al. report that BALB/cBy mice restricted the in-
fection to the small intestine following oral infection. The
MLN of BALB/cBy mice never became colonized with Y. en-
terocolitica, while those of C57BL/6 mice did (26). BALB/cBy
and BALB/cj are substrains that were separated from the orig-
inal BALB/c mouse strain in 1935 (21). Very little is known
about the differences between the two substrains other than
the variation existing at the nonpolymorphic major histocom-
patibility complex class I-like antigen locus, Qa-2 (30). BALB/
cBy have a large genomic deletion resulting in a Qa-2 pheno-
type, while BALB/cj are Qa-2; this may be important when
considering pathogens which colonize areas of the small intes-
tine. The presence of the unique subset of intestinal intraepi-
thelial lymphocytes, the CD8/ T cells, is dependent on the
presence of the Qa-2 locus (18). Therefore, CD8/ T cells are
not present in BALB/cBy mice but are present in BALB/cj
mice. Little is known about the specific role of CD8/ T cells
in the host response to bacterial pathogens. However, it is
hypothesized that they are a resident population that does not
participate in antigen-specific immune responses, but may play
a role in localized immune regulation (24). It is interesting to
speculate that CD8/ T cells may play a role in dissemination
from the PP to the MLN or in other host responses restricting
Y. enterocolitica to the small intestine.
The data presented here may also differ from previous re-
ports due to differences in mouse source and bacterial strain
(2, 9–12, 26, 27). The C57BL/6 and BALB/c mice used in the
present study were acquired from The Jackson Laboratory in
Bar Harbor, Maine. Autenrieth et al. and Bohn et al. acquired
C57BL/6 and BALB/c mice for their studies from Charles
River Wiga in Sulzfeld, Germany. Both of these mouse strains
have been continuously inbred from the same original breed-
ing stocks; however, it is possible that subtle differences due to
environmental conditions could affect experimental outcomes.
Furthermore, while we used Y. enterocolitica strain JB580v, the
other groups used strain WA; both strains are serotype O8 and
are considered to be highly virulent. To be certain that both the
mouse and bacterial strains used in the present study exhibited
similar phenotypes previously described in other laboratories,
we completed an LD50 analysis using mice obtained from The
Jackson Laboratory and i.v.-administered Y. enterocolitica
JB580v. Similar to previously reported data, the C57BL/6j
mouse strain was more resistant to i.v.-administered Y. entero-
colitica strain JB580v than was the BALB/cj strain. Therefore,
both the mouse and Y. enterocolitica strains used in this study
produced a similar response to that reported in previous stud-
ies. Data acquired comparing the differences in the mouse
strains infected orally with Y. enterocolitica strain JB580v ver-
sus mice infected i.v. should be valid and useful.
In view of the differences between our oral infection model
and previous studies in which an i.v. infection model was used,
we were interested in determining whether cellular and mo-
lecular immune phenotypes recognized as being important
during the host response to Y. enterocolitica also differed. In
addition, we were interested in characterizing and quantifying
critical molecular and cellular components of the immune re-
sponse following an oral Y. enterocolitica infection in tissues
commonly colonized following an oral infection. The results
from our Th1-Th2 cytokine analysis confirm observations
made by other researchers that a Th1 environment, with high
levels of IFN- and low levels of IL-4 and IL-5, predominates
during a Y. enterocolitica infection (10, 12, 27). We found this
to be true in PP, MLN, and spleens of all mouse strains.
TNF- production also increased as infection progressed.
Beuscher et al. have demonstrated that there is no TNF-
protein production in BALB/c PP 6 days after oral infection
1654 HANDLEY ET AL. INFECT. IMMUN.
 o
n
 January 29, 2014 by W
ashington University in St. Louis
http://iai.asm
.org/
D
ow
nloaded from
 
with Y. enterocolitica as determined by immunostaining and in
ex vivo tissue and cell culture assays (8). The reduction in
TNF- protein production is due to the YopB protein, en-
coded by the virulence plasmid of Y. enterocolitica. In addition,
both YopP for Y. enterocolitica and YopJ for Y. pseudotuber-
culosis have been assigned roles for decreasing the amount of
TNF- produced in macrophage cell culture (17). Similarly,
the virulence-associated V antigen (LcrV) can decrease TNF-
production in stimulated macrophages through the induction
of IL-10 (33). Therefore, there are at least three mechanisms
by which Y. enterocolitica can actively suppress TNF- levels.
The experiments presented here do not address whether any
TNF- suppression is occurring due to bacterial or host fac-
tors. Therefore, although we see increased levels of TNF-
throughout the 7-day course of infection, it is impossible to
detect the extent of TNF- suppression occurring in the tissues
analyzed.
There were few major differences in tissue cytokine levels
between the mouse strains. PP of BALB/cj mice had increased
TNF- production compared to C57BL/6j and 129X1/Svj mice.
Since these tissues were equally colonized with bacteria at this
stage in infection, this was probably a result of differences
between mouse strains. TNF- levels in the MLN were de-
creased between days 3 and 7 postinfection in both C57BL/6j
and BALB/cj mice; this differed from TNF- production in
129X1/Svj mice, which produced a smaller but more consistent
amount during this time. TNF- production increased in the
spleens of 129X1/Svj mice compared to that in the spleens of
C57BL/6j and BALB/cj mice. Along with increased TNF-
production, there was an increase in IFN- production and a
slight increase in IL-2 production. The heightened cytokine
response in the spleens of 129X1/Svj mice may explain the
decreased bacterial colonization observed throughout infec-
tion compared to that in C57BL/6j and BALB/cj mice.
Previous studies have shown that T cells isolated from
spleens of i.v.-infected C57BL/6 mice produce more IFN- on
exposure to HKY than do BALB/c splenic T cells (2). In-
creased IFN- production was seen as early as day 2 postin-
fection and increased steadily through day 10, eventually de-
creasing to levels comparable to those in BALB/c mice by day
20. Our data demonstrate that following oral infection, there
was no difference in IFN- production by C57BL/6j and
BALB/cj mouse splenocytes stimulated with HKY. However, a
difference was seen between 129X1/Svj and both C57BL/6j and
BALB/cj mouse strains. PP from the BALB/cj mouse strain
were better IFN- producers than those from both the
C57BL/6j and 129X1/Svj mouse strains. Although there ap-
pears to be some level of difference between these mouse
strains, the difference also appears to be dependent on the
route of infection and the tissue being analyzed.
To further characterize the oral-infection model, it was use-
ful to perform FACS analysis on several immune cell types
involved in both the innate and adaptive immune responses.
This was done not only to corroborate findings found using
other routes of infection and to assess differences between
mouse strains but also to determine the levels of important
immune cell types in a tissue-specific manner following oral
infection. Quantitative differences in cell type were seen be-
tween each mouse strain and also between the different lym-
phoid tissues. However, cell types typically recruited during an
inflammatory response to Y. enterocolitica and to bacteria in
general were found in all mouse strains and all tissues during
our analysis.
Taken together, our data emphasize that when using a
mouse model to study disease pathology and immunological
response, it is important to take into consideration not only the
mouse strain but also the way in which the bacteria are admin-
istered. Although some of our data correspond to results of
previous studies which utilized an i.v. infection model (e.g.,
Th1 bias and recruitment of neutrophils and macrophages),
overall pathological conditions such as differences between
mouse strains in LD50, rate of death, and bacterial colonization
of specific tissues do not agree when using an oral-infection
model. Both infection models have proven useful in the dis-
covery of many molecular and cellular mechanisms involved in
the pathogenesis of Y. enterocolitica. Future comparative stud-
ies using both model systems will be useful for elucidating new
mechanisms in which the mammalian host recognizes and de-
fends against bacteria by using the mucosal and the systemic
immune responses.
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